Department of Genetics, Wroclaw Medical University, Wroclaw, Poland.
Horm Metab Res. 2012 Sep;44(9):704-7. doi: 10.1055/s-0032-1312666. Epub 2012 Jun 13.
Resistance to thyroid hormone (RTH) syndrome is caused by mutations in THRB gene and is inherited mainly as an autosomal dominant trait with dominant negative effect. Most of up-to-now described RTH cases were heterozygous. We studied a 19-year-old woman presenting severe mental impairment, hyperkinetic behavior, learning disability, hearing loss, tachycardia, goiter, strabismus, nystagmus, and normal stature. The laboratory findings revealed elevated TSH, T3, and T4 serum levels. Her parents were healthy with normal serum level of TSH, fT3, and fT4. Sequence based prediction of a substitution was analyzed by SDM, PolPhen, and SNAP software whereas structural visualizations were performed in UCSF Chimera. We found a novel mutation in THRB gene in position 1216 (G to A transition, codon 311) resulting in novel Glu-311-Lys (p.E311K) substitution, homozygous in proband presenting with severe symptoms of RTH and heterozygous in both of her healthy parents, thus suggesting autosomal recessive mode of inheritance. p.E311K substitution was not found in 50 healthy, unrelated individuals. p.E311K was shown to be deleterious by SDM, PolPhen, and SNAP software. Structural visualizations of mutated protein performed by UCSF Chimera software disclosed a loss of hydrogen bonds between E311, R383, and R429 along with abnormal residue-residue contact between K311 and L377. This is a very rare case of a homozygous mutation in a patient with severe symptoms of RTH and lack of symptoms in both heterozygous parents. Although, computational analyses have provided the evidence that p.E311K substitution may affect THRB function, lack of dominant negative effect typical for THRB mutations could not be explained by structure-based modeling. Further in vitro analysis is required to assess the functional consequences of this substitution.
甲状腺激素抵抗综合征(RTH)是由 THRB 基因突变引起的,主要以常染色体显性遗传方式遗传,具有显性负效应。迄今为止描述的大多数 RTH 病例都是杂合的。我们研究了一位 19 岁的女性,她表现出严重的智力障碍、多动行为、学习障碍、听力损失、心动过速、甲状腺肿、斜视、眼球震颤和正常身高。实验室检查结果显示血清 TSH、T3 和 T4 水平升高。她的父母身体健康,血清 TSH、fT3 和 fT4 水平正常。通过 SDM、PolPhen 和 SNAP 软件对取代的序列进行了基于预测的分析,而结构可视化则在 UCSF Chimera 中进行。我们在 THRB 基因的 1216 位发现了一个新的突变(G 到 A 的转换,密码子 311),导致新的 Glu-311-Lys(p.E311K)取代,纯合子在表现出严重 RTH 症状的先证者中发现,而在她的两个健康父母中则为杂合子,因此提示常染色体隐性遗传模式。在 50 名健康、无关的个体中未发现 p.E311K 取代。SDM、PolPhen 和 SNAP 软件表明 p.E311K 取代是有害的。通过 UCSF Chimera 软件进行的突变蛋白结构可视化显示,E311、R383 和 R429 之间的氢键丢失,以及 K311 和 L377 之间异常的残基-残基接触。这是一个非常罕见的病例,患者为纯合突变,症状严重,而杂合父母均无症状。尽管计算分析提供了证据表明 p.E311K 取代可能影响 THRB 功能,但结构建模无法解释 THRB 突变典型的显性负效应缺失。需要进一步的体外分析来评估这种取代的功能后果。